Doug Hurst
banner
drhursty.bsky.social
Doug Hurst
@drhursty.bsky.social
Scientific Director, Biochemistry and Immunology of Cancer at the American Cancer Society
Our Chief Scientific Officer at the American Cancer Society, Bill Dahut, discusses the annual report that was released today. @goodmorningamerica.bsky.social @acscan.bsky.social www.goodmorningamerica.com/wellness/vid...
American Cancer Society releases annual report
Dr. William Dahut, the chief scientific officer at the American Cancer Society, discusses this year's findings — including that certain cancers are more likely to be seen in women and younger ad...
www.goodmorningamerica.com
January 16, 2025 at 2:45 PM
I feel extremely blessed to work at the American Cancer Society. We have seen lots of change during the past year, but importantly, we funded $132 million in new grants that included several new grant mechanisms! I am excited for 2025 and am looking forward to what the new year will bring!!!
December 20, 2024 at 8:46 PM
Interested in the grants admin side of cancer research? The ACS Clinical and Population Science Program is recruiting a Program Manager. Prefer experience in etiology, prevention, screening/detection, treatment, and/or survivorship. Fully remote position.
jobs.cancer.org/job/atlanta/...
Senior Associate Scientist (Program Manager) Description at AMERICAN CANCER SOCIETY
Learn more about applying for Senior Associate Scientist (Program Manager) at AMERICAN CANCER SOCIETY
jobs.cancer.org
December 17, 2024 at 2:20 PM
Congrats to the @ebos.bsky.social lab! Glad to see high impact publications from studies supported by the American Cancer Society Mission Boost Grant program! www.cancer.org/research/we-...
December 16, 2024 at 9:11 PM
Happy to see this mechanistic work from the @rothbartlab.bsky.social lab supported in part from the American Cancer Society!
Thrilled to share a new study from the lab revealing an H3K18ub-H3K9me3 crosstalk mechanism, roles for UHRF1 and its E3 ligase activity in regulating a hierarchy of repressive histone methylation signaling, and a strategy for targeting SUV39H1/H2 to improve DNMT1 inhibitor efficacy! #epigenetics
DNA hypomethylation promotes UHRF1-and SUV39H1/H2-dependent crosstalk between H3K18ub and H3K9me3 to reinforce heterochromatin states
Liu et al. report that DNMT1 inhibition causes transient accumulation of hemi-methylated DNA at CpG islands, which stimulates UHRF1-mediated H3K18ub. This enhances SUV39H1/H2 activity, nucleates new H...
www.cell.com
December 10, 2024 at 3:39 PM